A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens
- Publication date
- 1 January 2017
- Publisher
- 'Frontiers Media SA'